Tamir Biotechnology, Inc. (formerly Alfacell Corporation) targeting microRNAs, is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials.
Company Description:
the product candidate, onconase®, is an rnase that overcomes the challenges of targeting rna for therapeutic purposes while enabling the development of a new class of therapies for cancer, viral, and other life-threatening diseases.
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)